Latest News
Sophia Space and SLI Set Terms for $300 Million Asset Financing for 10-Satellite High-Performance Edge Computing Constellation
/PRNewswire/ -- Sophia Space today announced a $300 million financing framework with aerospace leasing specialist, SLI, for a planned 10-satellite

Upcoming Meeting Dates - September 14, 2026
Toronto, Ontario--(Newsfile Corp. - September 14, 2026) - The following is a list of Upcoming Meeting Dates announced this week

Youth Explore China Through the Grand Canal, a Glimpse of the North China Tour of GYLD Grand Canal Tour
Beijing, China--(Newsfile Corp. - September 14, 2026) - From Sept. 8 to 11, the North China Tour of the GYLD

Aignostics lanza PathoSearch, un motor de búsqueda visual para casos de patología
/PRNewswire/ -- Aignostics anunció el pasado día 12 el lanzamiento en acceso anticipado de PathoSearch, un motor de búsqueda visual para casos de patología. A
Cyble ernennt Cybersicherheitsexperten Steve Ingram zum Executive Vice President USA, um die Marktexpansion voranzutreiben
/PRNewswire/ -- Cyble, ein KI-natives Cybersicherheitsunternehmen, gab die Ernennung von Steve Ingram zum Executive Vice President USA bekannt, während das

VO: Excellent Wrapper, But Weak Entry Point
Vanguard Morningstar Mid-Cap ETF is rated Sell due to overvaluation and insufficient return versus required yield. VO trades at 23x earnings and 3.37x book, with a 5-year annualized return estimate of

Baker Hughes sees no slowdown in energy projects despite higher rates as AI buildouts stoke LNG demand
Baker Hughes has yet to see higher borrowing costs slow investment in energy projects. AI and data-center growth are supporting demand for natural gas and power generation.

Jeronimo Martins: Upside Or Persistent Weakness, I Look At 2026-2028E
Jerónimo Martins remains a 'BUY' at €17.9/share, but I lower my price target to €18.5 due to slower-than-expected earnings growth. Operationally, JRONY shows margin recovery and strong volume growth,

UiPath Targets AI-Powered Growth Reacceleration as ARR Hits $1.94B
UiPath NYSE: PATH Chief Operating Officer Ashim Gupta said the company is focused on stabilizing growth and positioning its automation platform for reacceleration as enterprises expand their use of ar

Trump says U.S. may keep Iranian oil 'like Venezuela' as Gulf-Iran Hormuz talks stall
Trump said the U.S. could take control of Iran's oil, likening the scenario to the deal Washington struck with Venezuela earlier this year. A meeting in Oman between Gulf countries and Iran to discuss

'Travel China with the Spring Festival Gala' new season captivates audiences with fresh take on urban cultural tourism
/PRNewswire/ -- "Travel China with the Spring Festival Gala" invites viewers to step into mountains and seas and discover that each city holds a thousand years

Trump says US can 'easily' afford $1.2T price tag for $5K dividend to adults
Donald Trump doubled down on his pledge to send $5,000 checks to every American adult if Republicans win the midterm elections, saying the country can easily afford the payments.

Vertiv Sees Data Center Demand Strengthen as AI Infrastructure Pipeline Expands
Vertiv NYSE: VRT executives said demand for data center infrastructure remains strong and is showing signs of further strengthening, citing expanding customer pipelines, broader global activity and ac

Accro Bioscience Announces Inclusion of AC-101 tablets in the NMPA CDE's "Caring Plan-Extension" Pilot Program for Rare Disease Drug Development
/PRNewswire/ -- On September 14, 2026 (China Standard Time, UTC+8), Accro Bioscience announced that AC-101 tablets have been included in the Rare Diseases

Silk Road Cultural Market Full of Charm: Highlights Chinese Traditional Food Culture
Shenzhen, China--(Newsfile Corp. - September 13, 2026) - On September 3, the "Read the Asia-Pacific · Discover Shenzhen" - 2026

Alexandria Real Estate: Despite Headwinds, It Remains A Buy
Alexandria Real Estate Equities (ARE) remains a Buy, supported by a compelling margin of safety despite headwinds. ARE faces persistent supply-demand imbalances in key life science markets, but recent

Johnson & Johnson's RYBREVANT® (amivantamab-vmjw) plus chemotherapy delivers longest reported median overall survival in EGFR exon 20 insertion mutation-positive lung cancer
RYBREVANT plus chemotherapy demonstrates durable benefit with a differentiated approach that dual-targets EGFR and MET Results mark significant progress for a patient population with poor outcomes and

The 10-year Treasury is closing in on 5%. How it gets there matters more
The 10-year Treasury yield is closing in on 5%, a level last touched in October 2023. A growth-driven rise could be manageable, while inflation, fiscal concerns or market stress pose greater risks.

KQQQ: Why I'd Own This Over QQQI Right Now
Kurv Technology Titans Select ETF maintains a buy rating due to its selective, actively managed option strategy and strong income potential. KQQQ's estimated 14.5% yield and active management allow dy

Whitehawk Therapeutics Presents Real-World Analyses Supporting PTK7 as a Durable ADC Target in EGFR Wild-Type Non-Small Cell Lung Cancer at WCLC 2026
PTK7 Expression Remained Stable Following Standard-of-Care Therapies, Supporting Its Relevance as a Target in Second- or Later-Line EGFR NSCLC Findings Reinforce the Scientific Rationale for HWK-007,